NCT00696917 - Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y | Biotech Hunter

Enrollment

1,303

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

February 29, 2000

Conditions

Hepatitis B

Interventions

BIOLOGICAL

HBV-MPL vaccine 208129

2-dose intramuscular injection 3 different vaccine lots

BIOLOGICAL

Engerix™-B

3-dose intramuscular injection

Trial Locations (7)

GSK Clinical Trials Call Center, Parkville

GSK Clinical Trials Call Center, Hradec Kralové

GSK Clinical Trials Call Center, München

GSK Clinical Trials Call Center, Bari

GSK Clinical Trials Call Center, Utrecht

GSK Clinical Trials Call Center, Lausanne

GSK Clinical Trials Call Center, London